Race Oncology Share Price and Company Fundamentals
Last traded: Today at 5:10 AM
Racura Oncology Ltd operates as a Phase 3 clinical biopharmaceutical company for cancer care. Its lead asset is RCDS1 (E,E-bisantrene), a small molecule anticancer agent that primarily functions through G4-DNA & RNA binding to potent inhibition of the cancer growth regulator MYC. The company is advancing a proprietary formulation of RCDS1 (RC220) to address the unmet needs of patients across various oncology indications with Phase 3 clinical programs in acute myeloid leukaemia, Phase 1a/b program in mutant epidermal growth factor receptor non-small cell lung cancer (EGFRm NSCLC), and a Phase 1a/b program in combination with the anthracycline doxorubicin. It has collaborations with Astex, MD Anderson, Sheba City of Health, UNC School of Medicine, University of Wollongong, and University of Newcastle. The company was formerly known as Race Oncology Ltd and changed its name to Racura Oncology Ltd in December 2025. Racura Oncology Ltd was incorporated in 2011 and is headquartered in Sydney, Australia.
Key Metrics
PE ratio
-
PB ratio
24.89
Dividend yield
-
Beta
0.91
Market cap
$415.30M
Enterprise value
$384.21M
Company profile
| Industry / Sector | Biotechnology / Healthcare |
|---|---|
| Website | https://www.racuraoncology.com |
| Mailing address | Gateway, 1 Macquarie Place Level 36 Sydney NSW 2000 Australia |
| Phone / Fax | 61 2 8051 3043 / |
Dividends
More: Race Oncology Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Race Oncology paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.RAC dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Race Oncology.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Dr. Peter Michael Smith Ph.D. | Executive Chairman | 62 | |
| Dr. Daniel Tillett | CEO, MD & Director | ||
| Mr. Brendan Brown | Chief Financial Officer | ||
| Dr. Sophia Moscovis | Vice President of Operations & Strategy | ||
| Dr. Jose L. Iglesias M.D. | Chief Medical Officer | 68 | |
| Mr. Peter Gordon Webse B.Bus, FCIS, FCPA, FGIA, M.A.I.C.D. | Company Secretary | 62 |
Profitability and management effectiveness
Profit margin
-79.22%
Operating margin
-621.91%
Return on assets
-15.63%
Return on equity
-27.89%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Race Oncology is 415.30M and its enterprise value is 384.21M. The enterprise value to revenue ratio of RAC is 63.58. The enterprise value to EBITDA ratio of RAC is -86.65.
The RAC's stocks Beta value is 0.91 making it 9% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Race Oncology (RAC)
Race Oncology (ASX:RAC) Frequently Asked Questions
1. What is Race Oncology's Stock Symbol?
Race Oncology trades on ASX under the ticker symbol "RAC".
2. What is Race Oncology's stock price today?
One share of RAC stock can currently be purchased for approximately $2.29.
3. How can I contact Race Oncology?
Race Oncology's mailing address is Gateway, 1 Macquarie Place Level 36 Sydney NSW 2000 Australia. The company can be reached via phone at 61 2 8051 3043.
4. What is Race Oncology's official website?
The official website of Race Oncology is https://www.racuraoncology.com.